Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks SoThe Motley Fool • 04/28/26
LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics AcquisitionZacks Investment Research • 04/28/26
Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli LillyThe Motley Fool • 04/28/26
Countdown to Lilly (LLY) Q1 Earnings: Wall Street Forecasts for Key MetricsZacks Investment Research • 04/27/26
As Investors Focus on Lilly's Foundayo, They May Be Overlooking Another Key CatalystBarrons • 04/27/26
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia veraPRNewsWire • 04/27/26
Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 04/23/26
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q1 EarningsZacks Investment Research • 04/23/26